Institutional Ownership Sab Biotherapeutics Inc Wt Exp (SABSW)
This table provides information about the institutional ownership of Sab Biotherapeutics Inc Wt Exp (SABSW). We have compiled data on the 12 institutions that hold shares in the stock, with a total of 353,663 shares, which have been reported (via 13F filing form) to have a value of $10,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
146,439
shares
|
$4,393
0.0% of portfolio
|
Q2 2024
Reduced 1.68%
|
|
|
Yakira Capital Management, Inc.
Westport, CT |
Nov 13, 2024 Q3 2024 |
108,485
shares
|
$3,254
0.0% of portfolio
|
Q1 2022
Reduced 6.3%
|
|
|
Hb Wealth Management, LLC
|
Jan 15, 2025 Q4 2024 |
50,001
shares
|
$1,500
0.0% of portfolio
|
Q4 2024
Reduced 83.87%
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
23,258
shares
|
$697
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Walleye Trading LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
15,505
shares
|
$465
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Wolverine Asset Management LLC
|
Feb 03, 2025 Q4 2024 |
8,655
shares
|
$259
0.0% of portfolio
|
Q4 2024
Reduced 44.23%
|
|
|
New Edge Advisors, LLC
New Orleans, LA |
Nov 14, 2024 Q3 2024 |
1,072
shares
|
$32
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Clear Street LLC
|
Nov 14, 2024 Q3 2024 |
200
shares
|
$6
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
48
shares
|
$1
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|